M A Moyad

Summary

Affiliation: University of Michigan
Country: USA

Publications

  1. ncbi request reprint Bladder cancer recurrence: Part II. What do I tell my patients about lifestyle changes and dietary supplements?
    Mark A Moyad
    University of Michigan Medical Center, Department of Urology, Ann Arbor, Michigan 48109 0330, USA
    Curr Opin Urol 13:379-83. 2003
  2. ncbi request reprint Preventing male osteoporosis: prevalence, risks, diagnosis and imaging tests
    Mark A Moyad
    Department of Urology, University of Michigan Medical Center, 1500 East Medical Center Drive, Ann Arbor, MI 48109 0330, USA
    Urol Clin North Am 31:321-30. 2004
  3. pmc What do most erectile dysfunction guidelines have in common? No evidence-based discussion or recommendation of heart-healthy lifestyle changes and/or Panax ginseng
    Mark A Moyad
    Department of Urology, Ann Arbor, MI 49109 0330, USA
    Asian J Androl 14:830-41. 2012
  4. doi request reprint The optimal male health diet and dietary supplement program
    Mark A Moyad
    Department of Urology, University of Michigan Medical Center, Ann Arbor, USA
    Urol Clin North Am 39:89-107. 2012
  5. ncbi request reprint Heart healthy equals prostate healthy equals statins: the next cancer chemoprevention trial. Part II
    Mark A Moyad
    Department of Urology, University of Michigan Medical Center, Ann Arbor, Michigan 48109 0330, USA
    Curr Opin Urol 15:7-12. 2005
  6. ncbi request reprint Heart healthy equals prostate healthy equals statins: the next cancer chemoprevention trial. Part I
    Mark A Moyad
    Department of Urology, University of Michigan Medical Center, Ann Arbor, Michigan 48109 0330, USA
    Curr Opin Urol 15:1-6. 2005
  7. ncbi request reprint Lifestyle recommendations to prevent prostate cancer, part II: time to redirect our attention?
    Mark A Moyad
    Department of Urology, University of Michigan Medical Center, 1500 East Medical Center Drive, Ann Arbor, MI 48109 0330, USA
    Urol Clin North Am 31:301-11. 2004
  8. ncbi request reprint Lifestyle recommendations to prevent prostate cancer, part I: time to redirect our attention?
    Mark A Moyad
    Department of Urology, University of Michigan Medical Center, 1500 East Medical Center Drive, Ann Arbor, MI 48109 0330, USA
    Urol Clin North Am 31:289-300. 2004
  9. ncbi request reprint Prevention and treatment of erectile dysfunction using lifestyle changes and dietary supplements: what works and what is worthless, part II
    Mark A Moyad
    Department of Urology, University of Michigan Medical Center, 1500 East Medical Center Drive, Ann Arbor, MI 48109 0330, USA
    Urol Clin North Am 31:259-73. 2004
  10. ncbi request reprint Prevention and treatment of erectile dysfunction using lifestyle changes and dietary supplements: what works and what is worthless, part I
    Mark A Moyad
    Department of Urology, University of Michigan Medical Center, 1500 East Medical Center Drive, Ann Arbor, MI 48109 0330, USA
    Urol Clin North Am 31:249-57. 2004

Detail Information

Publications77

  1. ncbi request reprint Bladder cancer recurrence: Part II. What do I tell my patients about lifestyle changes and dietary supplements?
    Mark A Moyad
    University of Michigan Medical Center, Department of Urology, Ann Arbor, Michigan 48109 0330, USA
    Curr Opin Urol 13:379-83. 2003
    ....
  2. ncbi request reprint Preventing male osteoporosis: prevalence, risks, diagnosis and imaging tests
    Mark A Moyad
    Department of Urology, University of Michigan Medical Center, 1500 East Medical Center Drive, Ann Arbor, MI 48109 0330, USA
    Urol Clin North Am 31:321-30. 2004
    ..This and other articles should provide a good foundation for clinicians to alter the increasing prevalence of a medical condition that is one of the most preventable causes of morbidity and mortality in men...
  3. pmc What do most erectile dysfunction guidelines have in common? No evidence-based discussion or recommendation of heart-healthy lifestyle changes and/or Panax ginseng
    Mark A Moyad
    Department of Urology, Ann Arbor, MI 49109 0330, USA
    Asian J Androl 14:830-41. 2012
    ..Ignoring the consistent, positive data on lifestyle modifications in ED guidelines, for example, is tantamount to ignoring diet and lifestyle changes to reduce the risk of or ameliorate cardiovascular diseases...
  4. doi request reprint The optimal male health diet and dietary supplement program
    Mark A Moyad
    Department of Urology, University of Michigan Medical Center, Ann Arbor, USA
    Urol Clin North Am 39:89-107. 2012
    ..This article provides recommendations to assist the clinician and patient to make practical changes that may be accomplished in a short period of time, and should provide tangible overall benefit for men's health...
  5. ncbi request reprint Heart healthy equals prostate healthy equals statins: the next cancer chemoprevention trial. Part II
    Mark A Moyad
    Department of Urology, University of Michigan Medical Center, Ann Arbor, Michigan 48109 0330, USA
    Curr Opin Urol 15:7-12. 2005
    ..Serum cholesterol levels are some of the most accurate long-term predictors of all-cause mortality. CVD has been the number one cause of death in the largest dietary supplement cancer chemoprevention trials...
  6. ncbi request reprint Heart healthy equals prostate healthy equals statins: the next cancer chemoprevention trial. Part I
    Mark A Moyad
    Department of Urology, University of Michigan Medical Center, Ann Arbor, Michigan 48109 0330, USA
    Curr Opin Urol 15:1-6. 2005
    ....
  7. ncbi request reprint Lifestyle recommendations to prevent prostate cancer, part II: time to redirect our attention?
    Mark A Moyad
    Department of Urology, University of Michigan Medical Center, 1500 East Medical Center Drive, Ann Arbor, MI 48109 0330, USA
    Urol Clin North Am 31:301-11. 2004
    ..What is heart-healthy is prostate-healthy, which makes it more likely that any man concerned about the risk for prostate cancer will make healthy lifestyle changes...
  8. ncbi request reprint Lifestyle recommendations to prevent prostate cancer, part I: time to redirect our attention?
    Mark A Moyad
    Department of Urology, University of Michigan Medical Center, 1500 East Medical Center Drive, Ann Arbor, MI 48109 0330, USA
    Urol Clin North Am 31:289-300. 2004
    ..It is imperative to provide patients with realistic and practical recommendations that are not only consistent in the medical literature, but will improve overall compliance...
  9. ncbi request reprint Prevention and treatment of erectile dysfunction using lifestyle changes and dietary supplements: what works and what is worthless, part II
    Mark A Moyad
    Department of Urology, University of Michigan Medical Center, 1500 East Medical Center Drive, Ann Arbor, MI 48109 0330, USA
    Urol Clin North Am 31:259-73. 2004
    ..The coming years of research should bring enormous excitement and objectivity to this area of medicine...
  10. ncbi request reprint Prevention and treatment of erectile dysfunction using lifestyle changes and dietary supplements: what works and what is worthless, part I
    Mark A Moyad
    Department of Urology, University of Michigan Medical Center, 1500 East Medical Center Drive, Ann Arbor, MI 48109 0330, USA
    Urol Clin North Am 31:249-57. 2004
    ..The time is more than ripe for patients to understand that heart health is tantamount to erectile health...
  11. ncbi request reprint Prostate cancer and coronary heart disease: correlation or coincidence?
    Mark A Moyad
    Department of Urology, University of Michigan Medical Center, 1500 East Medical Center Drive, Ann Arbor, MI 48109 0330, USA
    Urol Clin North Am 31:207-12. 2004
    ..The marriage between general preventive medicine and urology seems to be inevitable, and in the authors' opinion, this merger will provide the foundation for novel research that could affect patients' lives dramatically...
  12. ncbi request reprint Introduction to risk assessment and serum risk markers for the prevention of coronary heart disease and other potential conditions that impact men's health, part II: what do I tell my patients?
    Mark A Moyad
    Department of Urology, University of Michigan Medical Center, 1500 East Medical Center Drive, Ann Arbor, MI 48109 0330, USA
    Urol Clin North Am 31:199-205. 2004
    ....
  13. ncbi request reprint Introduction to risk assessment and serum risk markers for the prevention of coronary heart disease and other potential conditions that impact men's health, part I: what do I tell my patients?
    Mark A Moyad
    Department of Urology, University of Michigan Medical Center, 1500 East Medical Center Drive, Ann Arbor, MI 48109 0330, USA
    Urol Clin North Am 31:195-8. 2004
    ..It is hoped that this overview will assist clinicians and patients in raising the awareness of CHD as the leading cause of mortality in men, and help to place the overall risk for mortality into a proper perspective...
  14. ncbi request reprint The potential benefits of dietary and/or supplemental calcium and vitamin D
    Mark A Moyad
    Department of Urology, University of Michigan Medical Center, 1500 East Medical Center Drive, Ann Arbor, MI 48109 0330, USA
    Urol Oncol 21:384-91. 2003
    ..Clinicians need to encourage individuals to receive the recommended daily allowance of these two agents because they seem to have an impact on numerous health conditions besides osteoporosis...
  15. ncbi request reprint Osteoporosis: a rapid review of risk factors and screening methods
    Mark A Moyad
    Department of Urology, University of Michigan Medical Center, 1500 East Medical Center Drive, Ann Arbor, MI 48109 0330, USA
    Urol Oncol 21:375-9. 2003
    ..All of these imaging tests contain an inherent number of advantages and limitations. This brief review serves as a simplistic but important primer to a condition that is increasing in prevalence in a diverse area of medical fields...
  16. ncbi request reprint Why a statin and/or another proven heart healthy agent should be utilized in the next major cancer chemoprevention trial: part II
    Mark A Moyad
    Department of Urology, University of Michigan Medical Center, Ann Arbor, MI 48109 6804, USA
    Urol Oncol 22:472-7. 2004
    ..The time seems more than overdue for a statin and/or another cholesterol lowering or heart healthy cancer chemoprevention trial...
  17. ncbi request reprint Improving overall men's health and potentially reducing the risk of certain cancers via serum markers and risk assessment for coronary heart disease
    Mark A Moyad
    Department of Urology, University of Michigan Medical Center, 1500 East Medical Center Drive, Ann Arbor, MI 48109 0330, USA
    Urol Oncol 22:485-9. 2004
    ....
  18. doi request reprint Heart health = urologic health and heart unhealthy = urologic unhealthy: rapid review of lifestyle changes and dietary supplements
    Mark A Moyad
    Department of Urology, University of Michigan Medical Center, 1500 East Medical Center Drive, Ann Arbor, MI 48109 0330, USA
    Urol Clin North Am 38:359-67. 2011
    ....
  19. doi request reprint Statin Clinical Trial (REALITY) for prostate cancer: an over 15-year wait is finally over thanks to a dietary supplement
    Mark A Moyad
    Department of Urology, University of Michigan Medical Center, 1500 East Medical Center Drive, Ann Arbor, MI 48109 0330, USA
    Urol Clin North Am 38:325-31. 2011
    ..RYR appears to be an adequate proxy for some statins as long as quality control is monitored. The REALITY (REduction in Active surveillance Lipid Indices Through Yeast of red rice) trial will be conducted in Toronto, Canada...
  20. doi request reprint Molecular markers that can be utilized in diet and dietary supplement research
    Mark A Moyad
    Department of Urology, University of Michigan Medical Center, 1500 East Medical Center Drive, Ann Arbor, MI 48109 0330, USA
    Urol Clin North Am 38:321-4. 2011
    ..Testing of numerous molecular markers has become critical in gaining preliminary insight into the potential impact of a novel diet and supplemental agents...
  21. doi request reprint Promoting wellness for patients on androgen deprivation therapy: why using numerous drugs for drug side effects should not be first-line treatment
    Mark A Moyad
    Department of Urology, University of Michigan Medical Center, 1500 East Medical Center Drive, Ann Arbor, MI 48109 0330, USA
    Urol Clin North Am 38:303-12. 2011
    ..The hope is that patients will no longer be considered passive participants in the prevention and treatment of ADT side effects, now that information is available to help mitigate many of these effects...
  22. doi request reprint Vitamin C metabolites, independent of smoking status, significantly enhance leukocyte, but not plasma ascorbate concentrations
    Mark A Moyad
    Department of Urology, University of Michigan Medical Center, Ann Arbor, Michigan 48109 0330, USA
    Adv Ther 25:995-1009. 2008
    ..The objective of this study was to test the effects of acute doses of vitamin C alone, calcium ascorbate with vitamin C metabolites, and placebo, on total plasma and leukocyte vitamin C concentrations over 24 hours...
  23. doi request reprint Educating patients about lifestyle modifications for prostate health
    Mark A Moyad
    Department of Urology, University of Michigan Medical Center, Ann Arbor, Michigan 48109 0330, USA
    Am J Med 121:S34-42. 2008
    ..Patients need to know that a heart-healthy lifestyle is also a prostate-healthy lifestyle. This article provides educational and lifestyle recommendations that may favorably affect BPH and improve overall health in men...
  24. ncbi request reprint Step-by-step lifestyle changes that can improve urologic health in men, part II: What do I tell my patients?
    Mark A Moyad
    University of Michigan Medical Center, Department of Urology, 1500 East Medical Center Drive, Ann Arbor, MI 48109 0330, USA
    Prim Care 33:165-85, ix-x. 2006
  25. ncbi request reprint Step-by-step lifestyle changes that can improve urologic health in men, part I: What do I tell my patients?
    Mark A Moyad
    University of Michigan Medical Center, Department of Urology, 1500 East Medical Center Drive, Ann Arbor, MI 48109 0330, USA
    Prim Care 33:139-63, ix. 2006
  26. ncbi request reprint Promoting general health during androgen deprivation therapy (ADT): a rapid 10-step review for your patients
    Mark A Moyad
    Phil F Jenkins Director of Complementary and Alternative Medicine, Department of Urology, University of Michigan Medical Center, Ann Arbor, 48109 0330, USA
    Urol Oncol 23:56-64. 2005
    ....
  27. ncbi request reprint Statins and cholesterol lowering after a cancer diagnosis: why not?
    Mark A Moyad
    Phil F Jenkins Director of Complementary and Alternative Medicine, Department of Urology, University of Michigan Medical Center, Ann Arbor, 48109 0330, USA
    Urol Oncol 23:49-55. 2005
    ....
  28. ncbi request reprint An introduction to dietary/supplemental omega-3 fatty acids for general health and prevention: part II
    Mark A Moyad
    Phil F Jenkins Director of Complementary and Alternative Medicine, Department of Urology, University of Michigan Medical Center, Ann Arbor, 48109 0330, USA
    Urol Oncol 23:36-48. 2005
    ....
  29. ncbi request reprint An introduction to dietary/supplemental omega-3 fatty acids for general health and prevention: part I
    Mark A Moyad
    Phil F Jenkins Director of Complementary and Alternative Medicine, Department of Urology, University of Michigan Medical Center, Ann Arbor, 48109 0330, USA
    Urol Oncol 23:28-35. 2005
    ....
  30. ncbi request reprint Why a statin and/or another proven heart healthy agent should be utilized in the next major cancer chemoprevention trial: part I
    Mark A Moyad
    Department of Urology, University of Michigan Medical Center, Ann Arbor, MI 48109 0330, USA
    Urol Oncol 22:466-71. 2004
    ..The time seems more than overdue for a statin and/or another cholesterol lowering or heart healthy cancer chemoprevention trial...
  31. ncbi request reprint Selenium and vitamin E supplements for prostate cancer: evidence or embellishment?
    Mark A Moyad
    Department of Urology, University of Michigan Medical Center, Ann Arbor, Michigan 48109 0330, USA
    Urology 59:9-19. 2002
    ..Some evidence for the use of these supplements exists, but serious embellishment of study findings may be leading to an inappropriate use of these supplements in a clinical setting...
  32. ncbi request reprint Complementary/alternative therapies for reducing hot flashes in prostate cancer patients: reevaluating the existing indirect data from studies of breast cancer and postmenopausal women
    Mark A Moyad
    Department of Urology, University of Michigan Medical Center, Ann Arbor, Michigan 48109 0330, USA
    Urology 59:20-33. 2002
    ..Ultimately, adequate research (vs placebo) should determine the fate of the alternative supplements proposed for hot flash reduction...
  33. ncbi request reprint Is obesity a risk factor for prostate cancer, and does it even matter? A hypothesis and different perspective
    Mark A Moyad
    Department of Urology, University of Michigan Medical Center, Ann Arbor, Michigan 48109 0330, USA
    Urology 59:41-50. 2002
    ....
  34. ncbi request reprint Dietary fat reduction to reduce prostate cancer risk: controlled enthusiasm, learning a lesson from breast or other cancers, and the big picture
    Mark A Moyad
    Department of Urology, University of Michigan Medical Center, Ann Arbor, Michigan 48109 0330, USA
    Urology 59:51-62. 2002
    ..Numerous ongoing prospective studies of diet and cancer should provide researchers and the public with much-needed answers in this area...
  35. ncbi request reprint Dietary supplements and other alternative medicines for erectile dysfunction. What do I tell my patients?
    Mark A Moyad
    Department of Urology, University of Michigan Medical Center, 1500 East Medical Center Drive, Ann Arbor, MI 48109 0330, USA
    Urol Clin North Am 29:11-22, vii. 2002
    ....
  36. ncbi request reprint Lifestyle/dietary supplement partial androgen suppression and/or estrogen manipulation. A novel PSA reducer and preventive/treatment option for prostate cancer?
    Mark A Moyad
    Department of Urology, University of Michigan Medical Center, 1500 East Medical Center Drive, Ann Arbor, MI 48109 0330, USA
    Urol Clin North Am 29:115-24, ix. 2002
    ..Numerous mechanisms have been suggested as to how these interventions may lower PSA levels. However, it is possible that the primary mechanism of action is partial androgen suppression and/or estrogen manipulation...
  37. ncbi request reprint The placebo effect and randomized trials: analysis of conventional medicine
    Mark A Moyad
    Department of Urology Complementary and Alternative Medicine, University of Michigan Medical Center, 1500 East Medical Center Drive, Ann Arbor, MI 48109 0330, USA
    Urol Clin North Am 29:125-33, ix-x. 2002
    ..This article will review a whole series of unique conditions (allergies/asthma, alopecia, BPH, erectile dysfunction, osteoporosis, weight loss...) and the placebo response associated with them from conventional medical randomized trials...
  38. ncbi request reprint Potential lifestyle and dietary supplement options for the prevention and postdiagnosis of bladder cancer
    Mark A Moyad
    Department of Urology, University of Michigan Medical Center, 1500 East Medical Center Drive, Ann Arbor, MI 48109 0330, USA
    Urol Clin North Am 29:31-48, viii. 2002
    ..Advising patients on some of these lifestyle modifications is currently recommended because the majority of them are also currently recommended for cardiovascular disease reduction...
  39. ncbi request reprint The use of complementary/preventive medicine to prevent prostate cancer recurrence/progression following definitive therapy: part I--lifestyle changes
    Mark A Moyad
    Department of Urology, University of Michigan Medical Center, 1500 East Medical Center Drive, Ann Arbor, MI 48109 0330, USA
    Curr Opin Urol 13:137-45. 2003
    ..Patients need to be encouraged to know their cholesterol levels and other cardiovascular markers including blood pressure, as well as being aware of their prostate-specific antigen values...
  40. ncbi request reprint Mind-body effect: insulinlike growth factor-1; clinical depression; and breast, prostate, and other cancer risk-an unmeasured and masked mediator of potential significance?
    Mark A Moyad
    Department of Urology, University of Michigan Medical Center, Ann Arbor, Michigan 48109 0330, USA
    Urology 59:4-8. 2002
    ..The time seems ripe to at least define further the relation, if any, between IGF-1 and depression...
  41. ncbi request reprint The use of complementary/preventive medicine to prevent prostate cancer recurrence/progression following definitive therapy. Part II--rapid review of dietary supplements
    Mark A Moyad
    Department of Urology, University of Michigan Medical Center, 1500 East Medical Center Drive, Ann Arbor, MI 48109 0330, USA
    Curr Opin Urol 13:147-51. 2003
    ..Several supplements should be discussed with a patient following definitive prostate cancer therapy...
  42. ncbi request reprint Bladder cancer prevention. Part I: what do I tell my patients about lifestyle changes and dietary supplements?
    Mark A Moyad
    University of Michigan, Medical Center Department of Urology, Ann Arbor, Michigan 48109 0330, USA
    Curr Opin Urol 13:363-78. 2003
    ..Comprehensive reviews of lifestyle changes and dietary supplements that may prevent bladder cancer are needed in order to facilitate discussions between clinicians and patients...
  43. ncbi request reprint Fat reduction to prevent prostate cancer: waiting for more evidence?
    M A Moyad
    Section of Urology, University of Michigan Medical Center, Ann Arbor, Michigan 48109 0330, USA
    Curr Opin Urol 11:457-61. 2001
    ..Whether such therapies impact on prostate carcinoma remains to be determined through additional prospective investigations...
  44. ncbi request reprint The placebo effect and randomized trials: analysis of alternative medicine
    Mark A Moyad
    Department of Urology, University of Michigan Medical Center, 1500 East Medical Center Drive, Ann Arbor, MI 48109 0330, USA
    Urol Clin North Am 29:135-55, x. 2002
    ..for a number of non-urologic and urologic conditions, including cancer...
  45. ncbi request reprint Obesity, interrelated mechanisms, and exposures and kidney cancer
    M A Moyad
    Department of Surgery, University of Michigan Medical Center, Ann Arbor 48109-0330, USA
    Semin Urol Oncol 19:270-9. 2001
    ..Regardless of the actual cancer risk now and in the future, the overall effect of obesity on general health is clear, and this should be kept in mind in the discussion between health professional and patient...
  46. ncbi request reprint Review of potential risk factors for kidney (renal cell) cancer
    M A Moyad
    Department of Surgery, University of Michigan Medical Center, Ann Arbor 48109-0330, USA
    Semin Urol Oncol 19:280-93. 2001
    ....
  47. ncbi request reprint An introduction to aspirin, NSAids, and COX-2 inhibitors for the primary prevention of cardiovascular events and cancer and their potential preventive role in bladder carcinogenesis: part II
    M A Moyad
    Department of Surgery, University of Michigan Medical Center, Ann Arbor 48109-0330, USA
    Semin Urol Oncol 19:306-16. 2001
    ....
  48. ncbi request reprint Results and lessons from clinical trials using dietary supplements for cancer: direct and indirect investigations
    M A Moyad
    Department of Surgery, University of Michigan Medical Center, Ann Arbor 48109-0330, USA
    Semin Urol Oncol 19:232-46. 2001
    ..In addition, indirect trials for other conditions (cardiovascular) may provide future insight into possible results for future cancer prevention trials...
  49. ncbi request reprint Current methods used for defining, measuring, and treating obesity
    M A Moyad
    Department of Surgery, University of Michigan Medical Center, Ann Arbor 48109-0330, USA
    Semin Urol Oncol 19:247-56. 2001
    ..Unless therapy is individualized, it may be difficult to reverse the dramatic trends in obesity rates that have been observed over the past several decades...
  50. ncbi request reprint The prevalence and effectiveness of complementary and alternative medicine: what has been learned and what it may be telling us about our patients, ourselves, and conventional medical treatment
    M A Moyad
    Department of Surgery, University of Michigan Medical Center, Ann Arbor 48109-0330, USA
    Semin Urol Oncol 19:257-69. 2001
    ....
  51. ncbi request reprint An introduction to aspirin, NSAIDs, and COX-2 inhibitors for the primary prevention of cardiovascular events and cancer and their potential preventive role in bladder carcinogenesis: part I
    M A Moyad
    Department of Surgery, University of Michigan Medical Center, Ann Arbor 48109-0330, USA
    Semin Urol Oncol 19:294-305. 2001
    ..A few already available over-the-counter products and prescriptions seem to be receiving attention as possible anticancer agents...
  52. ncbi request reprint Cholesterol, cholesterol-lowering agents/statins, and urologic disease: Part VI--The recent rise and fall of the HDL-boosting drug torceptrapib
    Mark A Moyad
    University of Michigan Medical Center, Department of Urology, Ann Arbor, MI, USA
    Urol Nurs 27:169-73. 2007
    ..Despite the current interest in drug development, traditional HDL-boosting lifestyle initiatives such as exercise, weight loss, and smoking cessation can be incorporated now and are heart and urologic healthy...
  53. ncbi request reprint Alternative medicine utilization by African Americans and improving life expectancy: is there a correlation?
    Mark A Moyad
    University of Michigan Medical Center, Department of Urology, Ann Arbor, MI, USA
    Urol Nurs 27:449-50, 459. 2007
    ....
  54. ncbi request reprint Cholesterol, cholesterol lowering agents/statins, and urologic disease: part I - knowing your numbers
    Mark A Moyad
    University of Michigan Medical Center, Department of Urology, Ann Arbor, USA
    Urol Nurs 26:156-9. 2006
    ....
  55. ncbi request reprint Cholesterol, cholesterol lowering agents/statins, and urologic disease: part II--do you know your Framingham Risk Score?
    Mark A Moyad
    University of Michigan Medical Center, Department of Urology, Ann Arbor, MI, USA
    Urol Nurs 26:227-9, 203. 2006
  56. ncbi request reprint Cholesterol, cholesterol-lowering agents/statins, and urologic disease: Part V--Statins versus aspirin for primary prevention, and the winner is...?
    Mark A Moyad
    University of Michigan Medical Center, Department of Urology, Ann Arbor, MI, USA
    Urol Nurs 27:166-8. 2007
    ..In addition, patients should be informed about the recent observational data suggesting that statins may reduce mortality from other causes such as prostate cancer...
  57. ncbi request reprint Statins, especially atorvastatin, may improve survival following brachytherapy for clinically localized prostate cancer
    Mark A Moyad
    University of Michigan Medical Center, Department of Urology, Ann Arbor, MI, USA
    Urol Nurs 26:298-303. 2006
    ..A prospective trial of statin medications in conjunction with definitive local treatment for prostate cancer is recommended...
  58. ncbi request reprint Cholesterol, cholesterol-lowering agents/statins, and urologic disease: Part III--A rapid review of FDA-approved cholesterol-lowering agents
    Mark A Moyad
    University of Michigan Medical Center, Department of Urology, Ann Arbor, MI, USA
    Urol Nurs 26:330-2. 2006
    ..The bottom line is that practitioners have a large diversity of medications available for cholesterol lowering, and this is enormously exciting at a time when these agents have such profound effects in a variety of disciplines...
  59. ncbi request reprint Cholesterol, cholesterol-lowering agents/statins, and urologic disease: Part IV--is vitamin E phosphate or another unique type of this vitamin the last chance for these supplements?
    Mark A Moyad
    Complementary Medicine, University of Michigan Medical Center, Department of Urology, Ann Arbor, MI, USA
    Urol Nurs 26:415-8. 2006
    ..Until vitamin E demonstrates meaningful changes in some of the accepted markers of CVD prevention, it will be difficult to espouse their use specifically for these and other conditions...
  60. ncbi request reprint Statins, especially atorvastatin, may favorably influence clinical presentation and biochemical progression-free survival after brachytherapy for clinically localized prostate cancer
    Mark A Moyad
    Department of Complementary Alternative Medicine, University of Michigan Medical Center, Ann Arbor, Michigan, USA
    Urology 66:1150-4. 2005
    ..To conduct a preliminary investigation on statin use and its impact on clinical presentation and biochemical progression-free survival after brachytherapy...
  61. ncbi request reprint Osteoporosis. Part III--Not just for bone loss: potential benefits of calcium and vitamin D for overall general health
    Mark A Moyad
    University of Michigan Medical Center, Department of Urology, Ann Arbor, MI, USA
    Urol Nurs 23:69-74. 2003
    ..Vitamin D may play a role in cancer prevention, provide synergism or enhancement to some chemotherapy protocols, prevent Type I diabetes, and along with calcium reduce the risk of tooth loss...
  62. ncbi request reprint Fad diets and obesity--Part I: Measuring weight in a clinical setting
    Mark A Moyad
    University of Michigan Medical Center, Department of Urology, Section of Urology, Ann Arbor, MI, USA
    Urol Nurs 24:114-9. 2004
    ..Health professionals should acquaint themselves with these different measurements in order to take the first step in bringing attention to and potentially treating a condition that affects virtually every medical discipline...
  63. ncbi request reprint Osteoporosis--Part II: Dietary and/or supplemental calcium and vitamin D
    Mark A Moyad
    University of Michigan Medical Center, Department of Urology, Ann Arbor, MI, USA
    Urol Nurs 22:405-9. 2002
    ..Calcium and vitamin D in moderation also have an excellent safety profile and may actually have benefits far beyond osteoporosis therapy...
  64. ncbi request reprint Intake of selected nutritional supplements by African-American men
    Sally P Weinrich
    School of Nursing, University of Louisville, Louisville, Kentucky 40292, USA
    Urology 64:1094-7. 2004
    ..To measure the self-reported intake of vitamins, selenium, vitamin E, and saw palmetto supplements in African-American men...
  65. ncbi request reprint Zinc for prostate disease and other conditions: a little evidence, a lot of hype, and a significant potential problem
    Mark A Moyad
    University of Michigan Medical Center Dept of Urology, Ann Arbor, MI, USA
    Urol Nurs 24:49-52. 2004
    ....
  66. ncbi request reprint What do I tell my patients about drinking water and the risk of bladder cancer?
    Mark A Moyad
    University of Michigan Medical Center Department of Urology, Ann Arbor, MI, USA
    Urol Nurs 23:371-7. 2003
    ..Health care professionals could play a large role in preventing bladder cancer by providing patients with new data on the impact of water quantity and quality on risk...
  67. ncbi request reprint Lifestyle changes to prevent BPH: heart healthy = prostate healthy
    Mark A Moyad
    University of Michigan Medical Center Dept of Urology, Ann Arbor, MI, USA
    Urol Nurs 23:439-41. 2003
    ..Patients should be told that factors that increase the risk of cardiovascular disease seem to be associated with an increased risk of BPH or a greater severity of BPH...
  68. ncbi request reprint Fad diets and obesity--Part IV: Low-carbohydrate vs. low-fat diets
    Mark A Moyad
    University of Michigan Medical Center, Department of Urology, Ann Arbor, MI, USA
    Urol Nurs 25:67-70. 2005
    ..The decision to go on any diet should be made with a health professional who can monitor the patient closely...
  69. ncbi request reprint Complementary therapies for reducing the risk of osteoporosis in patients receiving luteinizing hormone-releasing hormone treatment/orchiectomy for prostate cancer: a review and assessment of the need for more research
    Mark A Moyad
    Department of Urology, University of Michigan Medical Center, Ann Arbor, Michigan, USA
    Urology 59:34-40. 2002
    ..In the meantime, it is important to keep in mind that these complementary approaches are, at the very least, an integral part of the conventional options used today to the reduce the risk of osteoporosis in men and women...
  70. ncbi request reprint Abandoning isolated free PSA screenings for more comprehensive cardiovascular and cancer screening and education
    Mark A Moyad
    University of Michigan Medical Center, Department of Urology, Ann Arbor, MI, USA
    Urol Nurs 25:137-41. 2005
    ..Abandoning this myopic single-disease only approach must be embraced by numerous medical centers and health professionals before this comprehensive approach can be successfully implemented...
  71. ncbi request reprint Osteoporosis--Part I: Risk factors and screening
    Mark A Moyad
    University of Michigan Medical Center, Department of Urology, Ann Arbor, MI, USA
    Urol Nurs 22:276-9. 2002
    ..All of these tests contain an inherent number of advantages and limitations. This review serves as a simplistic but important introduction to a condition that is increasing in incidence in a variety of health care fields...
  72. ncbi request reprint CAM: definition and classification overview
    Jane Hokanson Hawks
    Midland Lutheran College, Fremont, NE, USA
    Urol Nurs 23:221-3. 2003
    ..An overview of the development of CAM definitions and classifications that summarize these developments follows...
  73. ncbi request reprint Brewer's/baker's yeast (Saccharomyces cerevisiae) and preventive medicine: part I
    Mark A Moyad
    University of Michigan Medical Center, Department of Urology, Ann Arbor, MI, USA
    Urol Nurs 27:560-1. 2007
    ..Yeast-based technology is also being used as a molecular mechanistic model of caloric restriction with the goal of improving the human life span. The current and potential impact of yeast-based technology in medicine is encouraging...
  74. ncbi request reprint What happened to the Provenge (Sipuleucel-T) vaccine for hormone refractory prostate cancer?
    Mark A Moyad
    University of Michigan Medical Center, Department of Urology, Ann Arbor, MI, USA
    Urol Nurs 27:256-7. 2007
    ..Regardless, the situation with Provenge is disappointing and should be re-evaluated...
  75. ncbi request reprint Rules to follow before advising patients on dietary supplements/alternative medicine: Part II
    Mark A Moyad
    University of Michigan Medical Center, Department of Urology, Ann Arbor, MI, USA
    Urol Nurs 22:173-7; quiz 178. 2002
    ..Finally, patients should be assured that data gathering on some of these alternatives are being collected at a rapid pace that should promote a better understanding of the benefits and detriments of certain supplements...
  76. ncbi request reprint Rules to follow before advising patients on dietary supplements/alternative medicine: Part I
    Mark A Moyad
    University of Michigan Medical Center, Department of Urology, Ann Arbor, MI, USA
    Urol Nurs 22:99-101, 104-10; quiz 111. 2002
    ..In Part I of this series, ten rules that can be generally applied or used in a clinical setting will be described. Rules to follow when patients inquire about CAM will be outlined in Part II...
  77. ncbi request reprint Osteoporosis and prostate cancer
    Mark A Moyad
    Urol Oncol 21:374. 2003